Vertex Pharmaceuticals Announces Webcast of its Presentation at the Bear Stearns Ninth Annual London Healthcare Conference.CAMBRIDGE, Mass. -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX An earlier real time operating system for embedded systems from Mentor Graphics, Wilsonville, OR (www.mentor.com). VRTX was the progenitor of the VxWorks OS from Wind River and was superseded by Nucleus OS. VRTX - Virtual Real-Time Executive. ) will webcast its corporate presentation at the Bear Stearns Ninth Annual London Healthcare Conference on Tuesday, February 27, 2007 at 11:20 a.m. GMT (Greenwich Mean Time) See UTC. GMT - Universal Time 1 (6:20 a.m. EST EST electroshock therapy. EST abbr. electroshock therapy ). The presentation will be webcast live and may be accessed from the 'Events Calendar' on the home page of Vertex's website at www.vrtx.com. A replay of the webcast will be available on the Company's website until March 13, 2007. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast. About Vertexo Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, inflammation, autoimmune diseases Autoimmune diseases A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs. Mentioned in: Complement Deficiencies, Premature Menopause , cancer, pain and bacterial infection. Vertex co-discovered the HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. protease inhibitor, Lexiva, with GlaxoSmithKline. Lexiva is a registered trademark of the GlaxoSmithKline group of companies. Vertex's press releases are available at www.vrtx.com. (VRTX-G) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion